Biomarkers in pediatric asthma: clinical maturity, intended use, and future directions.
Asthma in children is heterogeneous, and symptom-based assessment alone does not fully capture airway inflammation, future risk, or treatment responsiveness. A wide range of biomarkers has therefore been investigated, from clinically accessible inflammatory markers to emerging molecular and omics-based signatures. This...